---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-023096"
form_type: "8-K"
ticker: "QXL"
cik: "0000797542"
company_name: "Viewbix Inc."
filed_at: "2026-05-14T20:15:48+00:00"
generated_at: "2026-05-14T20:50:48.100901+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quantum X Labs files audited financials of acquired Quantum Israel; going concern cited

## Summary
- Quantum Israel had $0 revenue, net loss of $273k for Jan-Dec 2025; total assets $448k, cash $260k.
- Auditor's report includes going-concern emphasis: losses since incorporation, negative operating cash flow.
- Key asset: exclusive license from Tel Aviv University for quantum error correction technology.
- Company holds equity stakes in CliniQuantum (48%), Quantum Transportation (30%), Quantum Gyro (40%).
- Acquisition closed March 4, 2026; consideration includes shares and warrants representing 40% of issuer's capital plus milestone shares.

## SEC filing metadata
- accession: 0001493152-26-023096
- form_type: 8-K
- ticker: QXL
- cik: 0000797542
- company_name: Viewbix Inc.
- filed_at: 2026-05-14T20:15:48+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/797542/000149315226023096/0001493152-26-023096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/797542/000149315226023096/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-023096
- JSON: https://secwatch.observer/filing/0001493152-26-023096.json
- Plain text: https://secwatch.observer/filing/0001493152-26-023096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.